Browse 13 Therapeutics companies funded by BlackRock. See funding amounts, founder contacts, and investment details.
Annexon Biosciences is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.
OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.
Cellares is an Integrated Development and Manufacturing Organization dedicated to the automated, large-scale production of cell therapies.
Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.
Abcuro develops immunotherapies to treat autoimmunity and cancer.
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.
Vividion is a developer of a novel drug discovery platform designed to offer transformative treatments to patients with serious illnesses.
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.
View all companies funded by BlackRock across every industry and funding stage.
View Full BlackRock Portfolio